PaxMedica's Research on Low Dose Suramin for Autism
TARRYTOWN, N.Y. , Oct. 26, 2023 (GLOBE NEWSWIRE) -- via IBN -- PaxMedica, Inc. (Nasdaq: PXMD) a clinical-stage biopharmaceutical company, is excited to...
Source: globenewswire.com
Stay updated with breaking news from Miel Malan. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
TARRYTOWN, N.Y. , Oct. 26, 2023 (GLOBE NEWSWIRE) -- via IBN -- PaxMedica, Inc. (Nasdaq: PXMD) a clinical-stage biopharmaceutical company, is excited to...
TARRYTOWN, N.Y. , Oct. 26, 2023 -- via IBN -- PaxMedica, Inc. a clinical-stage biopharmaceutical company, is excited to announce that the Annals of General Psychiatry, an internationally...